ProfileGDS5678 / 1425939_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 17% 14% 14% 14% 14% 15% 15% 14% 14% 14% 14% 14% 14% 14% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4362317
GSM967853U87-EV human glioblastoma xenograft - Control 22.3519214
GSM967854U87-EV human glioblastoma xenograft - Control 32.3576114
GSM967855U87-EV human glioblastoma xenograft - Control 42.2996514
GSM967856U87-EV human glioblastoma xenograft - Control 52.3006514
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4236915
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4011715
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3350314
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3245514
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3463814
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3453814
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3279614
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3523214
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.350114